Petra E. van der Wouden

673 citations

21 papers · 517 indexed · h-index 12

Toxicology top 10%
- Bioactive Compounds and Antitumor Agents 2
Molecular Biology
- Epigenetics and DNA Methylation 4
- Protein Degradation and Inhibitors 4
- Histone Deacetylase Inhibitors Research 4
- Genomics and Chromatin Dynamics 3
Immunology
- Macrophage Migration Inhibitory Factor 7
Oncology
- Peptidase Inhibition and Analysis 5
Physiology
Cellular and Molecular Neuroscience
- Nuclear Receptors and Signaling 4

Co-authors: Frank J. Dekker Niek G.J. Leus Hidde J. Haisma Deng Chen Maria E. Ourailidou Loes Kistemaker Rainer Bischoff Reinoud Gosens
Cited by: Toxicology Molecular Biology Immunology
Journals: Angewandte Chemie International Edition (3 papers)Scientific Reports (1 paper)Journal of Medicinal Chemistry (5 papers)
Partner nations: Netherlands Germany Italy

In The Last Decade

Petra E. van der Wouden

20 papers receiving 512 citations

Peers

Countries citing papers authored by Petra E. van der Wouden

Since Specialization

Citations

This map shows the geographic impact of Petra E. van der Wouden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra E. van der Wouden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra E. van der Wouden more than expected).

Fields of papers citing papers by Petra E. van der Wouden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra E. van der Wouden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra E. van der Wouden. The network helps show where Petra E. van der Wouden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Petra E. van der Wouden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Petra E. van der Wouden Line = papers co-authored together Petra E. van der Wouden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Novel 15-lipoxygenase-1 inhibitor protects cells from RSL3-induced cell death European Journal of Medicinal Chemistry ·Jianqiu Zhang,Petra E. van der Wouden,Frank J. Dekker	2025	1
2	The synthesis of 1,2,3-triazoles as binders of D-dopachrome tautomerase (D-DT) for the development of dual-targeting inhibitors European Journal of Medicinal Chemistry ·Angelina Osipyan,Radu-George Bulai,Zhengyang Wu,J. Witte,Jesse J. H. van der Velde,Mohammed Abdul Kader,Petra E. van der Wouden,Gerrit J. Poelarends,Frank J. Dekker	2024	1
3	Protocol of the Double‐Click Seq Method to Evaluate the Deposition Bias of Chromatin Proteins Current Protocols ·Petra E. van der Wouden,Martijn R. H. Zwinderman,Deng Chen,Michela Borghesan,Frank J. Dekker	2023	0
4	Allosteric Inhibitors of Macrophage Migration Inhibitory Factor (MIF) Interfere with Apoptosis-Inducing Factor (AIF) Co-Localization to Prevent Parthanatos Journal of Medicinal Chemistry ·Deng Chen,Angelina Osipyan,Jeaunice Adriana,Mohammed Abdul Kader,Maxim Gureev,Catharina W. J. Knol,Marie‐Cathérine Sigmund,Zhangping Xiao,Petra E. van der Wouden,Robbert H. Cool,Gerrit J. Poelarends,Frank J. Dekker	2023	6
5	Histone Deacetylase 3‐Directed PROTACs Have Anti‐inflammatory Potential by Blocking Polarization of M0‐like into M1‐like Macrophages Angewandte Chemie International Edition ·Chunlong Zhao,Shipeng Chen,Deng Chen,Clàudia Río‐Bergé,Jianqiu Zhang,Petra E. van der Wouden,Toos Daemen,Frank J. Dekker	2023	14
6	Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione Derivative Inhibits d-Dopachrome Tautomerase Activity and Suppresses the Proliferation of Non-Small Cell Lung Cancer Cells Journal of Medicinal Chemistry ·Zhangping Xiao,Angelina Osipyan,Shanshan Song,Deng Chen,Reinder A. Schut,Ronald van Merkerk,Petra E. van der Wouden,Robbert H. Cool,Wim J. Quax,Barbro N. Melgert,Gerrit J. Poelarends,Frank J. Dekker	2022	22
7	Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells Angewandte Chemie ·Zhangping Xiao,Shanshan Song,Deng Chen,Ronald van Merkerk,Petra E. van der Wouden,Robbert H. Cool,Wim J. Quax,Gerrit J. Poelarends,Barbro N. Melgert,Frank J. Dekker	2021	3
8	Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells Angewandte Chemie International Edition ·Zhangping Xiao,Shanshan Song,Deng Chen,Ronald van Merkerk,Petra E. van der Wouden,Robbert H. Cool,Wim J. Quax,Gerrit J. Poelarends,Barbro N. Melgert,Frank J. Dekker	2021	37
9	Deposition Bias of Chromatin Proteins Inverts under DNA Replication Stress Conditions ACS Chemical Biology ·Martijn R. H. Zwinderman,Thamar Jessurun Lobo,Petra E. van der Wouden,Diana C.J. Spierings,Marcel A.T.M. van Vugt,Peter M. Lansdorp,Victor Guryev,Frank J. Dekker	2021	4
10	4‐Iodopyrimidine Labeling Reveals Nuclear Translocation and Nuclease Activity for Both MIF and MIF2** Chemistry - A European Journal ·Zhangping Xiao,Deng Chen,Fabian Mulder,Shanshan Song,Petra E. van der Wouden,Robbert H. Cool,Barbro N. Melgert,Gerrit J. Poelarends,Frank J. Dekker	2021	5
11	Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC) European Journal of Medicinal Chemistry ·Fangyuan Cao,Sander de Weerd,Deng Chen,Martijn R. H. Zwinderman,Petra E. van der Wouden,Frank J. Dekker	2020	63
12	7-Hydroxycoumarins Are Affinity-Based Fluorescent Probes for Competitive Binding Studies of Macrophage Migration Inhibitory Factor Journal of Medicinal Chemistry ·Zhangping Xiao,Deng Chen,Shanshan Song,Ramon van der Vlag,Petra E. van der Wouden,Ronald van Merkerk,Robbert H. Cool,Anna K. H. Hirsch,Barbro N. Melgert,Wim J. Quax,Gerrit J. Poelarends,Frank J. Dekker	2020	23
13	A next-generation sequencing method for gene doping detection that distinguishes low levels of plasmid DNA against a background of genomic DNA Gene Therapy ·Eddy N. de Boer,Petra E. van der Wouden,Lennart Johansson,Cleo C. van Diemen,Hidde J. Haisma	2019	33
14	Light-controlled inhibition of BRAFV600E kinase European Journal of Medicinal Chemistry ·Mark W. H. Hoorens,Maria E. Ourailidou,Theo Rodat,Petra E. van der Wouden,Piermichele Kobauri,Malte Kriegs,Christian Peifer,Ben L. Feringa,Frank J. Dekker,Wiktor Szymański	2019	32
15	Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity Journal of Medicinal Chemistry ·Hao Guo,Iris C. Verhoek,Grietje H. Prins,Ramon van der Vlag,Petra E. van der Wouden,Ronald van Merkerk,Wim J. Quax,Peter Olinga,Anna K. H. Hirsch,Frank J. Dekker	2019	20
16	HDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice Scientific Reports ·Niek G.J. Leus,Thea van den Bosch,Petra E. van der Wouden,Kim Krist,Maria E. Ourailidou,Nikolaos Eleftheriadis,Loes Kistemaker,Sophie Bos,Rutger A. F. Gjaltema,Solomon A. Mekonnen,Rainer Bischoff,Reinoud Gosens,Hidde J. Haisma,Frank J. Dekker	2017	64
17	The relevance of K i calculation for bi-substrate enzymes illustrated by kinetic evaluation of a novel lysine (K) acetyltransferase 8 inhibitor European Journal of Medicinal Chemistry ·Hannah Wapenaar,Thea van den Bosch,Niek G.J. Leus,Petra E. van der Wouden,Nikolaos Eleftheriadis,Jos Hermans,Gebremedhin Solomon Hailu,Dante Rotili,Antonello Mai,Alexander Dömlingꝉ,Rainer Bischoff,Hidde J. Haisma,Frank J. Dekker	2017	5
18	HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity Biochemical Pharmacology ·Niek G.J. Leus,Petra E. van der Wouden,Thea van den Bosch,Wouter T. R. Hooghiemstra,Maria E. Ourailidou,Loes Kistemaker,Rainer Bischoff,Reinoud Gosens,Hidde J. Haisma,Frank J. Dekker	2016	105
19	Enzyme kinetics and inhibition of histone acetyltransferase KAT8 European Journal of Medicinal Chemistry ·Hannah Wapenaar,Petra E. van der Wouden,Matthew R. Groves,Dante Rotili,Antonello Mai,Frank J. Dekker	2015	26
20	Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties Journal of Medicinal Chemistry ·Nikolaos Eleftheriadis,Constantinos G. Neochoritis,Niek G.J. Leus,Petra E. van der Wouden,Alexander Dömlingꝉ,Frank J. Dekker	2015	47

About Petra E. van der Wouden

Petra E. van der Wouden is a scholar working on Toxicology, Immunology and Cellular and Molecular Neuroscience, having authored 21 papers that have together received 517 indexed citations. Recurring topics across this work include Macrophage Migration Inhibitory Factor (7 papers), Peptidase Inhibition and Analysis (5 papers), Epigenetics and DNA Methylation (4 papers), Protein Degradation and Inhibitors (4 papers), Nuclear Receptors and Signaling (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Genomics and Chromatin Dynamics (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Toxicology (21 citations), Molecular Biology (340 citations) and Immunology (93 citations). Petra E. van der Wouden has collaborated with scholars based in Netherlands, Germany and Italy. Frequent co-authors include Frank J. Dekker, Niek G.J. Leus, Hidde J. Haisma, Deng Chen, Maria E. Ourailidou, Loes Kistemaker, Rainer Bischoff, Reinoud Gosens, Thea van den Bosch and Nikolaos Eleftheriadis. Their work appears in journals such as Angewandte Chemie International Edition, Scientific Reports and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact